Logo image of TOUR

TUNIU CORP-SPON ADR (TOUR) Stock Fundamental Analysis

NASDAQ:TOUR - Nasdaq - US89977P1066 - ADR - Currency: USD

0.87  0 (0%)

Fundamental Rating

5

Taking everything into account, TOUR scores 5 out of 10 in our fundamental rating. TOUR was compared to 131 industry peers in the Hotels, Restaurants & Leisure industry. TOUR has an average financial health and profitability rating. TOUR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year TOUR was profitable.
In the past year TOUR had a positive cash flow from operations.
TOUR had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: TOUR reported negative operating cash flow in multiple years.
TOUR Yearly Net Income VS EBIT VS OCF VS FCFTOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

1.2 Ratios

TOUR's Return On Assets of 4.03% is fine compared to the rest of the industry. TOUR outperforms 62.60% of its industry peers.
With a decent Return On Equity value of 7.12%, TOUR is doing good in the industry, outperforming 64.12% of the companies in the same industry.
TOUR has a Return On Invested Capital (6.07%) which is in line with its industry peers.
Industry RankSector Rank
ROA 4.03%
ROE 7.12%
ROIC 6.07%
ROA(3y)-3.76%
ROA(5y)-11.5%
ROE(3y)-6.63%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
TOUR Yearly ROA, ROE, ROICTOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

TOUR has a Profit Margin of 14.98%. This is amongst the best in the industry. TOUR outperforms 88.55% of its industry peers.
TOUR has a Operating Margin of 15.18%. This is in the better half of the industry: TOUR outperforms 67.18% of its industry peers.
TOUR's Gross Margin of 69.65% is amongst the best of the industry. TOUR outperforms 84.73% of its industry peers.
TOUR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.18%
PM (TTM) 14.98%
GM 69.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.93%
GM growth 5Y8.01%
TOUR Yearly Profit, Operating, Gross MarginsTOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

6

2. Health

2.1 Basic Checks

TOUR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for TOUR has been reduced compared to 1 year ago.
TOUR has less shares outstanding than it did 5 years ago.
The debt/assets ratio for TOUR has been reduced compared to a year ago.
TOUR Yearly Shares OutstandingTOUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TOUR Yearly Total Debt VS Total AssetsTOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of -4.78, we must say that TOUR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -4.78, TOUR is not doing good in the industry: 93.89% of the companies in the same industry are doing better.
TOUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -4.78
ROIC/WACC0.64
WACC9.47%
TOUR Yearly LT Debt VS Equity VS FCFTOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

TOUR has a Current Ratio of 1.35. This is a normal value and indicates that TOUR is financially healthy and should not expect problems in meeting its short term obligations.
TOUR has a better Current ratio (1.35) than 68.70% of its industry peers.
A Quick Ratio of 1.35 indicates that TOUR should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.35, TOUR is doing good in the industry, outperforming 71.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
TOUR Yearly Current Assets VS Current LiabilitesTOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

TOUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 177.78%, which is quite impressive.
The Revenue has grown by 16.45% in the past year. This is quite good.
The Revenue for TOUR have been decreasing by -25.77% on average. This is quite bad
EPS 1Y (TTM)177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.56%
Revenue 1Y (TTM)16.45%
Revenue growth 3Y6.46%
Revenue growth 5Y-25.77%
Sales Q2Q%3%

3.2 Future

Based on estimates for the next years, TOUR will show a very negative growth in Earnings Per Share. The EPS will decrease by -21.60% on average per year.
Based on estimates for the next years, TOUR will show a quite strong growth in Revenue. The Revenue will grow by 13.31% on average per year.
EPS Next Y-90.36%
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
EPS Next 5YN/A
Revenue Next Year13.23%
Revenue Next 2Y13.23%
Revenue Next 3Y13.31%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TOUR Yearly Revenue VS EstimatesTOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
TOUR Yearly EPS VS EstimatesTOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2023 2024 2025 2026 2027 0 -5 -10 -15

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.67, the valuation of TOUR can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of TOUR indicates a rather cheap valuation: TOUR is cheaper than 96.18% of the companies listed in the same industry.
TOUR is valuated cheaply when we compare the Price/Earnings ratio to 27.69, which is the current average of the S&P500 Index.
TOUR is valuated quite expensively with a Price/Forward Earnings ratio of 76.34.
65.65% of the companies in the same industry are cheaper than TOUR, based on the Price/Forward Earnings ratio.
TOUR's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 37.36.
Industry RankSector Rank
PE 9.67
Fwd PE 76.34
TOUR Price Earnings VS Forward Price EarningsTOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

TOUR's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. TOUR is cheaper than 78.63% of the companies in the same industry.
97.71% of the companies in the same industry are more expensive than TOUR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.73
EV/EBITDA 8.69
TOUR Per share dataTOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

TOUR's earnings are expected to decrease with -21.60% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%

3

5. Dividend

5.1 Amount

TOUR has a Yearly Dividend Yield of 3.33%.
Compared to an average industry Dividend Yield of 3.64, TOUR pays a better dividend. On top of this TOUR pays more dividend than 86.26% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, TOUR pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.33%

5.2 History

TOUR is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
TOUR Yearly Dividends per shareTOUR Yearly Dividends per shareYearly Dividends per share 2025 0 0 0 0 0

5.3 Sustainability

DPN/A
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
TOUR Yearly Income VS Free CF VS DividendTOUR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

TUNIU CORP-SPON ADR

NASDAQ:TOUR (7/24/2025, 11:01:40 AM)

0.87

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)06-02 2025-06-02
Earnings (Next)08-04 2025-08-04
Inst Owners9.95%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap102.41M
Analysts85.71
Price Target1.73 (98.85%)
Short Float %0.41%
Short Ratio0.83
Dividend
Industry RankSector Rank
Dividend Yield 3.33%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date03-27 2025-03-27 (0.036)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.67
Fwd PE 76.34
P/S 1.43
P/FCF 8.73
P/OCF 7.64
P/B 0.68
P/tB 0.76
EV/EBITDA 8.69
EPS(TTM)0.09
EY10.34%
EPS(NY)0.01
Fwd EY1.31%
FCF(TTM)0.1
FCFY11.46%
OCF(TTM)0.11
OCFY13.09%
SpS0.61
BVpS1.28
TBVpS1.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.03%
ROE 7.12%
ROCE 7.68%
ROIC 6.07%
ROICexc 6.07%
ROICexgc 6.82%
OM 15.18%
PM (TTM) 14.98%
GM 69.65%
FCFM 16.34%
ROA(3y)-3.76%
ROA(5y)-11.5%
ROE(3y)-6.63%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.93%
GM growth 5Y8.01%
F-Score8
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 192.93%
Cap/Sales 2.33%
Interest Coverage 26.17
Cash Conversion 113.99%
Profit Quality 109.09%
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z -4.78
F-Score8
WACC9.47%
ROIC/WACC0.64
Cap/Depr(3y)99.5%
Cap/Depr(5y)69.38%
Cap/Sales(3y)2.7%
Cap/Sales(5y)3.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.56%
EPS Next Y-90.36%
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
EPS Next 5YN/A
Revenue 1Y (TTM)16.45%
Revenue growth 3Y6.46%
Revenue growth 5Y-25.77%
Sales Q2Q%3%
Revenue Next Year13.23%
Revenue Next 2Y13.23%
Revenue Next 3Y13.31%
Revenue Next 5YN/A
EBIT growth 1Y477.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year525.42%
EBIT Next 3Y111.86%
EBIT Next 5YN/A
FCF growth 1Y-62.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.8%
OCF growth 3YN/A
OCF growth 5YN/A